{"id":"https://openalex.org/W2171422487","doi":"https://doi.org/10.1200/jco.2005.05.4494","title":"Predicting Vinorelbine Disposition and Toxicity: Does BSA Provide More Than a \u201cBad Statistical Association\u201d?","display_name":"Predicting Vinorelbine Disposition and Toxicity: Does BSA Provide More Than a \u201cBad Statistical Association\u201d?","publication_year":2006,"publication_date":"2006-05-02","ids":{"openalex":"https://openalex.org/W2171422487","doi":"https://doi.org/10.1200/jco.2005.05.4494","mag":"2171422487","pmid":"https://pubmed.ncbi.nlm.nih.gov/16651645"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2005.05.4494","doi":"https://doi.org/10.1200/jco.2005.05.4494","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2005.05.4494","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.05.4494?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"editorial","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.05.4494?role=tab","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077260725","display_name":"Sharyn D. Baker","orcid":"https://orcid.org/0000-0003-3062-3252","observed_orcids":["https://orcid.org/0000-0003-3062-3252"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharyn D. Baker","raw_affiliation_strings":["The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065279964","display_name":"Alex Sparreboom","orcid":"https://orcid.org/0000-0003-2660-6644","observed_orcids":["https://orcid.org/0000-0003-2660-6644"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex Sparreboom","raw_affiliation_strings":["National Cancer Institute, The National Institutes of Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Institute, The National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":"16","first_page":"2412","last_page":"2413"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.5151000022888184,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.5151000022888184,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.23080000281333923,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.06560000032186508,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/body-surface-area-dosing","display_name":"body surface area dosing","score":0.7870000004768372},{"id":"https://openalex.org/keywords/pharmacodynamic-variability","display_name":"pharmacodynamic variability","score":0.7400000095367432},{"id":"https://openalex.org/keywords/drug-clearance","display_name":"drug clearance","score":0.5950000286102295},{"id":"https://openalex.org/keywords/body-size","display_name":"body size","score":0.49300000071525574},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.4740000069141388},{"id":"https://openalex.org/keywords/rank-correlation","display_name":"rank correlation","score":0.4169999957084656},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.3400000035762787},{"id":"https://openalex.org/keywords/cancer-patients","display_name":"cancer patients","score":0.49000000953674316},{"id":"https://openalex.org/keywords/body-composition","display_name":"body composition","score":0.46700000762939453},{"id":"https://openalex.org/keywords/glomerular-filtration-rate","display_name":"glomerular filtration rate","score":0.6380000114440918}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7793620228767395},{"id":"https://openalex.org/C2780350996","wikidata":"https://www.wikidata.org/wiki/Q420532","display_name":"Vinorelbine","level":4,"score":0.7423171997070312},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6713788509368896},{"id":"https://openalex.org/C38022665","wikidata":"https://www.wikidata.org/wiki/Q1149305","display_name":"Disposition","level":2,"score":0.6123891472816467},{"id":"https://openalex.org/C142853389","wikidata":"https://www.wikidata.org/wiki/Q744778","display_name":"Association (psychology)","level":2,"score":0.4622286260128021},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4270709455013275},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4147437512874603},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3559117615222931},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.19841217994689941},{"id":"https://openalex.org/C77805123","wikidata":"https://www.wikidata.org/wiki/Q161272","display_name":"Social psychology","level":1,"score":0.10338550806045532},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.09473064541816711},{"id":"https://openalex.org/C542102704","wikidata":"https://www.wikidata.org/wiki/Q183257","display_name":"Psychotherapist","level":1,"score":0.0},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000077235","descriptor_name":"Vinorelbine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001830","descriptor_name":"Body Surface Area","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005240","descriptor_name":"Feasibility Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006402","descriptor_name":"Hematologic Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D018401","descriptor_name":"Sample Size","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D020641","descriptor_name":"Polymorphism, Single Nucleotide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049628","descriptor_name":"Body Size","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2005.05.4494","doi":"https://doi.org/10.1200/jco.2005.05.4494","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2005.05.4494","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.05.4494?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:16651645","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16651645","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Editorial"}],"best_oa_location":{"id":"doi:10.1200/jco.2005.05.4494","doi":"https://doi.org/10.1200/jco.2005.05.4494","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2005.05.4494","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.05.4494?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2171422487.pdf","grobid_xml":"https://content.openalex.org/works/W2171422487.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W144668201","https://openalex.org/W1518575821","https://openalex.org/W1944107108","https://openalex.org/W1971559706","https://openalex.org/W1982875149","https://openalex.org/W1991970935","https://openalex.org/W2020303409","https://openalex.org/W2026103827","https://openalex.org/W2027504487","https://openalex.org/W2105683481","https://openalex.org/W2112163451","https://openalex.org/W2112776466","https://openalex.org/W2169388316","https://openalex.org/W2169753547","https://openalex.org/W2409410491","https://openalex.org/W2885026042"],"related_works":["https://openalex.org/W2013529703","https://openalex.org/W2169388316","https://openalex.org/W4254548222","https://openalex.org/W144668201","https://openalex.org/W115054888","https://openalex.org/W2089426347","https://openalex.org/W2144766106","https://openalex.org/W2172797860","https://openalex.org/W7098869828","https://openalex.org/W2113199662"],"abstract_inverted_index":{"The":[0,441],"concept":[1],"that":[2,13,160,207,240,265,323,387,396,414,443,494,512,628,670,687,736],"chemotherapeutic":[3,77,472,541],"agents":[4,39,78],"are":[5,126,178,546,725,751],"administered":[6],"at":[7],"a":[8,14,58,62,70,95,107,135,163,254,273,309,332,356,364,436,498,508,592,633,675,706,746],"dose":[9,144,366],"to":[10,61,88,133,140,170,232,243,292,339,402,456,488,519,539,566,613,648,651,694,709,742],"the":[11,19,32,54,66,74,116,157,172,213,294,314,348,374,409,420,428,475,479,491,522,561,568,575,598,615,618,630,641,653,658,679,703,711,743],"maximum":[12],"patient":[15],"can":[16],"tolerate":[17],"before":[18,51],"onset":[20],"of":[21,57,69,76,119,156,246,283,297,311,316,358,367,373,376,427,432,438,551,563,571,579,582,617,637,655,682,705,713,745],"unacceptable":[22],"toxicity,":[23],"is":[24,40,49,84,148,241,268,308,398,459,496,560,690],"still":[25,127,547],"in":[26,44,100,142,218,230,236,275,279,299,331,355,370,504,640,678,684,722],"wide":[27,533],"clinical":[28],"use":[29,296],"today.":[30],"However,":[31],"therapeutic":[33],"range":[34],"for":[35,110,212,221,302,353,465,478,501,585,597],"most":[36,45],"cytotoxic":[37],"anticancer":[38,284,303],"extremely":[41],"narrow,":[42],"and":[43,82,103,124,152,154,195,249,350,416,424,461,484,528,535,588,603,605,663,686,698,728],"cases":[46],"no":[47],"information":[48,342],"available":[50],"therapy":[52],"on":[53,115,253,313,319,449,759],"intrinsic":[55],"sensitivity":[56],"patient\u2019s":[59,67],"tumor":[60],"particular":[63,747],"agent":[64,545],"or":[65],"tolerability":[68],"given":[71],"dose.":[72],"Hence,":[73],"dosage":[75],"remains":[79,487],"largely":[80],"empirical":[81],"it":[83,147],"typically":[85],"only":[86,280,421,629,674,737],"normalized":[87],"an":[89,337,450],"individual\u2019s":[90],"body-surface":[91],"area":[92],"(BSA).":[93],"From":[94],"pharmacologic":[96],"perspective,":[97],"interindividual":[98,234,276,320,404,453],"differences":[99,215,328,721],"body":[101,104,247,250,317],"size":[102,138,248,318],"composition":[105],"present":[106],"challenging":[108],"role":[109,677],"clinicians,":[111],"as":[112,146,435,467,469,757],"their":[113],"effects":[114],"time":[117],"course":[118],"drug":[120,143,169,174,219,586,708,750],"response":[121],"(ie,":[122],"toxicity":[123,447,486],"efficacy)":[125],"poorly":[128],"understood.":[129],"BSA":[130,165,208,298,388,397,415,444,483,495,527],"does":[131,209,324],"seem":[132],"be":[134,228,489,517,649,718],"biologically":[136],"plausible":[137],"descriptor":[139],"consider":[141],"calculation":[145],"derived":[149],"from":[150,327],"height":[151],"weight,":[153],"because":[155],"intuitive":[158],"belief":[159],"patients":[161,217,330,361,505],"with":[162,187,272,363,392,452,507,543],"larger":[164],"would":[166],"require":[167],"more":[168],"induce":[171],"same":[173],"effects.":[175],"Moreover,":[176],"there":[177,307],"some":[179],"data":[180],"describing":[181],"general":[182],"physiologic":[183],"characteristics":[184,570],"being":[185],"associated":[186,271],"BSA,":[188],"including":[189,753],"glomerular":[190],"filtration":[191],"rate,":[192],"blood":[193],"volume,":[194],"basal":[196],"metabolic":[197,680],"rate.":[198],"In":[199,336],"contrast,":[200],"many":[201,222],"studies":[202,667],"have":[203,262,668],"now":[204],"convincingly":[205],"demonstrated":[206],"not":[210,325,390,399,516,726],"account":[211],"marked":[214],"between":[216,329,482,526,657],"clearance":[220,418,639,744],"widely":[223,593],"used":[224,434,594,612],"agents,":[225],"which":[226,610],"may":[227,445,515],"due,":[229],"part,":[231],"large":[233],"variability":[235,278,322,458],"drug-metabolizing":[237],"enzyme":[238],"activity":[239,578,616,662],"known":[242],"exist":[244],"irrespective":[245],"composition.":[251],"Based":[252],"retrospective":[255],"analysis":[256],"involving":[257],"33":[258],"different":[259],"drugs,":[260],"we":[261],"previously":[263],"estimated":[264],"BSA-based":[266],"dosing":[267,300],"statistically":[269,422],"significantly":[270,400],"reduction":[274],"pharmacokinetic":[277,334,405],"approximately":[281],"15%":[282],"drugs.":[285],"This":[286],"notion":[287,442],"has":[288],"led":[289],"several":[290],"investigators":[291],"question":[293],"routine":[295],"strategies":[301],"agents.":[304,473],"Overall,":[305],"however,":[306],"deficit":[310],"knowledge":[312],"influence":[315],"pharmacodynamic":[321],"originate":[326],"drug\u2019s":[333],"profile.":[335],"attempt":[338],"overcome":[340],"this":[341,371,513,544,688],"deficit,":[343],"Wong":[344,383,557,624],"et":[345,384,558,625],"al":[346,385,559,626],"describe":[347],"feasibility":[349],"pharmacokinetic/pharmacodynamic":[351],"relationships":[352],"vinorelbine":[354,393,417,572,638,664,683],"group":[357],"41":[359],"cancer":[360],"treated":[362,506],"flat-fixed":[365],"60":[368],"mg":[369],"issue":[372],"Journal":[375],"Clinical":[377],"Oncology.":[378],"Using":[379,590],"rank":[380],"correlation":[381],"analyses,":[382],"demonstrate":[386],"did":[389],"correlate":[391],"clearance,":[394],"suggesting":[395],"contributing":[401,741],"explaining":[403],"variability.":[406],"Interestingly,":[407],"among":[408],"variables":[410],"tested,":[411],"they":[412],"found":[413,627],"were":[419],"significant":[423,634],"independent":[425,635],"predictors":[426],"post-treatment":[429],"fractional":[430],"survival":[431],"neutrophils,":[433],"measure":[437],"vinorelbine-induced":[439],"myelosuppression.":[440],"predict":[446,567,710],"based":[448],"association":[451,525],"pharmacodynamic\u2014as":[454],"opposed":[455],"pharmacokinetic\u2014":[457],"intriguing":[460],"warrants":[462],"additional":[463],"exploration":[464],"vinorelbine,":[466],"well":[468],"other":[470,714],"myelosuppressive":[471],"Although":[474],"underlying":[476],"mechanism":[477],"possible":[480,553],"link":[481],"hematologic":[485],"elucidated,":[490],"previous":[492],"finding":[493],"also":[497],"risk":[499],"factor":[500],"severe":[502],"leukopenia":[503],"vindesine/cisplatin-containing":[509],"regimen":[510],"suggests":[511],"effect":[514],"limited":[518],"vinorelbine.":[520],"Nonetheless,":[521],"currently":[523],"observed":[524,659],"vinorelbine-associated":[529],"neutropenia":[530],"shows":[531],"rather":[532],"scatter":[534],"hence":[536],"better":[537],"tools":[538,554],"individualize":[540],"treatment":[542],"highly":[548],"desired.":[549],"One":[550],"such":[552,756],"evaluated":[555],"by":[556,573],"application":[562],"probe":[564,596,707],"drugs":[565],"disposition":[569],"determining":[574],"baseline":[576],"phenotypic":[577,595,660],"two":[580],"proteins":[581],"putative":[583],"importance":[584],"distribution":[587],"elimination.":[589],"midazolam,":[591],"cytochrome":[599],"P450":[600],"isoforms":[601],"CYP3A4":[602,661,671,715,748],"CYP3A5,":[604],"technetium":[606],"labeled":[607],"sestamibi":[608],"(99mTc-MIBI),":[609],"was":[611,632],"determine":[614],"transporter":[619,723],"protein":[620],"ABCB1":[621],"(MDR1;":[622],"P-glycoprotein),":[623],"latter":[631],"predictor":[636],"34":[642],"assessable":[643],"patients.":[644],"Several":[645],"factors":[646,740],"need":[647],"considered":[650],"understand":[652],"lack":[654],"relationship":[656],"clearance.":[665],"Recent":[666],"indicated":[669],"probably":[672],"plays":[673],"modest":[676],"breakdown":[681],"vivo,":[685],"pathway":[689],"even":[691],"relatively":[692],"insensitive":[693],"inhibition":[695],"(by":[696,700],"ritonavir)":[697],"induction":[699],"rifampin).":[701],"Furthermore":[702],"ability":[704],"metabolism":[712],"substrates":[716],"will":[717],"compromised":[719],"if":[720],"affinities":[724],"identified":[727],"fully":[729],"taken":[730],"into":[731],"account.":[732],"It":[733],"logically":[734],"follows":[735],"once":[738],"all":[739],"substrate":[749],"known,":[752],"nonmetabolic":[754],"determinants":[755],"reliance":[758],"JOURNAL":[760],"OF":[761],"CLINICAL":[762],"ONCOLOGY":[763],"E":[764],"D":[765],"I":[766,770],"T":[767],"O":[768],"R":[769],"A":[771],"L":[772],"VOLUME":[773],"24":[774],"NUMBER":[775],"16":[776],"JUNE":[777],"1":[778],"2006":[779]},"counts_by_year":[{"year":2021,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}